The SCHD Reconstitution Paradox — Why the Fund Had to Sell Its Winners

The SCHD Reconstitution Paradox — Why the Fund Had to Sell Its Winners

The SCHD Reconstitution Paradox — Why the Fund Had to Sell Its Winners

·3 min read
Share

SCHD, America's most popular dividend ETF managing $99 billion, just dumped 22 stocks and replaced them with 25 new ones. The removed names were up an average of 6.7% this year. The replacements? Down 9.4% on average. A 16 percentage point swing in the wrong direction.

That looks reckless on the surface. It's actually the opposite.

SCHD Has No Portfolio Manager

SCHD tracks the Dow Jones US Dividend 100 index. Every year, the index runs its entire portfolio through a set of quality screens. No human picks what stays or goes — a formula does.

To qualify, a company must have paid dividends for at least 10 consecutive years. Every qualifying name gets scored on four metrics:

  • Return on equity
  • Cash flow relative to debt
  • Current dividend yield
  • Five-year dividend growth rate

The top 100 make the cut. Everyone else is out, regardless of how well their stock performed.

The Paradox: Why Winners Get Removed

Here's where it gets counterintuitive.

Energy stocks crushed it this year. Valero was up over 45%. But when a stock price surges, the dividend yield drops — it's a fixed dollar payout divided by a higher price. Lower yield means a lower quality score. The very performance that made these stocks portfolio winners is what pushed them below the top-100 threshold.

The fund sold its winners not because they failed, but because their success changed the math against them.

What Actually Happened in the Energy Rotation

Last year, SCHD made its biggest sector bet ever — loading energy from 12% to 21% of the fund. It worked brilliantly as the energy sector ripped higher.

This year, roughly $8 billion in energy stocks rotated out of the $99 billion fund. But the fund didn't abandon energy entirely. ConocoPhillips and Chevron remain in the top five holdings. Devon Energy was actually added — it's up over 27% this year.

The system kept the highest-quality energy names and cut the ones whose scores slipped. That's not panic selling. That's mechanical discipline.

Why the New Additions Look Weak

UnitedHealth, one of the largest additions by market cap, is down over 17% this year. On the surface, that looks like buying losers.

But SCHD's screening doesn't look at recent price performance. It evaluates ROE, cash flow, dividend yield, and dividend growth. When a stock drops, its yield goes up — and that can push its quality score higher.

This system isn't chasing momentum. It's finding the intersection of value and quality. The year's most unpopular stocks can score highest in the screening.

What This Reconstitution Means

SCHD doesn't hold on to yesterday's winners out of sentiment. It reruns the quality filter and rebuilds.

Will this portfolio miss a few more months of energy upside? Probably. But the discipline of selling names that score lower and replacing them with names that score higher is exactly what's kept this fund relevant for over a decade.

Twenty-two stocks swapped in one move sounds aggressive. Under the hood, it's the system doing precisely what it was built to do.

Share

Ecconomi

Finance & Economics major at a U.S. university. Securities report analyst.

Learn more
This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. Investment decisions should be made at your own discretion and risk.

Previous Posts

Ecconomi

A professional financial content platform providing in-depth analysis and investment insights on global financial markets.

Navigation

The content on this site is for informational purposes only and should not be construed as investment advice or financial guidance. Investment decisions should be made based on your own judgment and responsibility.

© 2026 Ecconomi. All rights reserved.